Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cerevel Therapeutics Holdings, Inc.CERE · Entity 15182 | Chief Legal Officer | October 27, 2020 | October 30, 2020 |
| Inspire Medical Systems, Inc.INSP · Entity 1186 | See Remarks | February 20, 2026 | February 25, 2026 |
| SURMODICS INCSRDX · Entity 72915 | SVP, Gen Counsel & Secretary | November 27, 2019 | December 02, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cerevel Therapeutics Holdings, Inc.
Report date October 27, 2020 · Filed October 30, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.92 · Expires 2030-02-19 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2020-10-27 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: 25% of the shares subject to this option will vest and become exercisable on January 2, 2021, with remainder vesting in 36 equal monthly installments thereafter. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.44 · Expires 2030-02-19 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2020-10-27 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F1: 25% of the shares subject to this option will vest and become exercisable on January 2, 2021, with remainder vesting in 36 equal monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of the shares subject to this option will vest and become exercisable on January 2, 2021, with remainder vesting in 36 equal monthly installments thereafter.
Inspire Medical Systems, Inc.
Report date February 20, 2026 · Filed February 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,513 |
Ending reported balance
After 2026-02-20 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-02-20 · Grant · Acquired 2,400 · Balance 14,891 F1: Reflects an award of shares of common stock following the satisfaction of performance conditions associated with previously granted performance stock units. Row 2 · 2026-02-20 · Tax withholding · Disposed 735 · Balance 14,156 F2: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Row 3 · 2026-02-20 · Grant · Acquired 15,958 · Balance 30,114 F3: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates. Row 4 · 2026-02-20 · Grant · Acquired 8,399 · Balance 38,513 F3: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects an award of shares of common stock following the satisfaction of performance conditions associated with previously granted performance stock units.
F2: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award.
F3: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates.
SURMODICS INC
Report date November 27, 2019 · Filed December 02, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,311 |
Ending reported balance
After 2019-11-30 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2019-11-27 · Tax withholding · Disposed 403 · Balance 36,411 Row 2 · 2019-11-28 · Tax withholding · Disposed 687 · Balance 35,724 Row 3 · 2019-11-30 · Tax withholding · Disposed 413 · Balance 35,311 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2026 Filed Feb 25, 2026 00:08 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 8,399 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-019288 · tm267181-6_4seq1.xml · nonDerivative · entry 4 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,513 F3 · shares: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 00:08 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 15,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-019288 · tm267181-6_4seq1.xml · nonDerivative · entry 3 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,114 F3 · shares: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 00:08 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 735 | $59.53 | $43,754.55 |
DisclosureSEC source: 0001104659-26-019288 · tm267181-6_4seq1.xml · nonDerivative · entry 2 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,156 F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 00:08 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-019288 · tm267181-6_4seq1.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,891 F1 · shares: Reflects an award of shares of common stock following the satisfaction of performance conditions associated with previously granted performance stock units. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 579 | $59.76 | $34,601.04 |
DisclosureSEC source: 0001104659-26-017039 · tm266746-1_4seq1.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,491 F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:21 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 327 | $66.33 | $21,689.91 |
DisclosureSEC source: 0001104659-26-013535 · tm266005-4_4seq1.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,070 F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. F2 · balance_after: Includes (i) 67 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2025 and (ii) 94 shares acquired under the Plan on December 31, 2025. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 2,206 | $186.45 | $411,308.70 |
DisclosureSEC source: 0001104659-25-017092 · tm257622-4_4seq1.xml · nonDerivative · entry 2 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,236 F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 6,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017092 · tm257622-4_4seq1.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,442 F1 · shares: Reflects an award of shares of common stock following the vesting of previously granted performance stock units. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:45 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 5,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-014863 · tm256927-5_4seq1.xml · nonDerivative · entry 3 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,290 F2 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 09, 2025 Filed Feb 18, 2025 23:45 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 282 | $182.15 | $51,366.30 |
DisclosureSEC source: 0001104659-25-014863 · tm256927-5_4seq1.xml · nonDerivative · entry 2 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,214 Read SEC document |
| January 29, 2025 Filed Feb 18, 2025 23:45 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 204 | $189.99 | $38,757.96 |
DisclosureSEC source: 0001104659-25-014863 · tm256927-5_4seq1.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,496 F1 · balance_after: Includes (i) 66 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2024 and (ii) 63 shares acquired under the Plan on December 31, 2024. Read SEC document |
| February 09, 2024 Filed Feb 14, 2024 02:50 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 4,376 | $0.00 Strike: $194.87 | $0.00 |
DisclosureSEC source: 0001104659-24-022577 · tm245999-9_4seq1.xml · derivative · entry 2 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,376 Underlying: Common Stock · 4,376 shares Expires 2034-02-09 F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 09, 2024 Filed Feb 14, 2024 02:50 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 2,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-022577 · tm245999-9_4seq1.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,571 F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| January 29, 2024 Filed Feb 1, 2024 01:48 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 205 | $216.61 | $44,405.05 |
DisclosureSEC source: 0001104659-24-008988 · tm244813-1_4seq1.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,877 F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. F2 · balance_after: Includes (i) 44 shares acquired under the Inspire Medical Systems, Inc. (the "Company") 2018 Employee Stock Purchase Plan (the "Plan") on December 31, 2021, (ii) 35 shares acquired under the Company Plan on June 30, 2023 and (iii) 43 shares acquired under the Company Plan on December 31, 2023. Read SEC document |
| February 10, 2023 Filed Feb 15, 2023 01:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 5,450 | $0.00 Strike: $263.16 | $0.00 |
DisclosureSEC source: 0001104659-23-022089 · tm236006-10_4seq1.xml · derivative · entry 1 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,450 Underlying: Common Stock · 5,450 shares Expires 2033-02-10 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 10, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| January 29, 2023 Filed Feb 1, 2023 00:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 205 | $253.24 | $51,914.20 |
DisclosureSEC source: 0001104659-23-008812 · tm235077-1_4seq1.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,960 F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. F2 · balance_after: Includes (i) 48 shares acquired under the Inspire Medical Systems, Inc. (the "Company") 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2022 and (ii) 47 shares acquired under the Company Plan on December 31, 2022. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 21:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 5,924 | $0.00 Strike: $227.53 | $0.00 |
DisclosureSEC source: 0001104659-22-023825 · tm226817-4_4seq1.xml · derivative · entry 1 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,924 Underlying: Common Stock · 5,924 shares Expires 2032-02-11 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of Feruary 11, 2022 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| January 29, 2022 Filed Jan 31, 2022 21:20 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 205 | $208.00 | $42,640.00 |
DisclosureSEC source: 0001104659-22-009574 · tm224900-1_4seq1.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,070 F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $201.51 | $0.00 |
DisclosureSEC source: 0001104659-21-010921 · a4.xml · derivative · entry 2 Phillips Bryan K · CIK 0001412895 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-01-29 F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of January 29, 2021 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 2,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-010921 · a4.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,275 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest in four equal installments on each of the first through fourth anniversaries of January 29, 2021, subject to the Reporting Person's continued employment with the Issuer through each applicable vesting date. Read SEC document |
| November 30, 2019 Filed Dec 2, 2019 16:10 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 413 | $41.04 | $16,949.52 |
DisclosureSEC source: 0001209191-19-058514 · doc4.xml · nonDerivative · entry 3 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,311 Read SEC document |
| November 28, 2019 Filed Dec 2, 2019 16:10 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 687 | $40.89 | $28,091.43 |
DisclosureSEC source: 0001209191-19-058514 · doc4.xml · nonDerivative · entry 2 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,724 Read SEC document |
| November 27, 2019 Filed Dec 2, 2019 16:10 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 403 | $40.89 | $16,478.67 |
DisclosureSEC source: 0001209191-19-058514 · doc4.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,411 Read SEC document |
| November 25, 2019 Filed Nov 27, 2019 15:28 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 3,581 | $42.00 | $150,402.00 |
DisclosureSEC source: 0001209191-19-058307 · doc4.xml · nonDerivative · entry 2 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,814 F2 · shares: Shares withheld to satisfy taxes incident to vesting of performance share award. Read SEC document |
| November 25, 2019 Filed Nov 27, 2019 15:28 UTC | SURMODICS INC SRDX · Entity 72915 | GrantCommon Stock | 7,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-058307 · doc4.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,395 F1 · shares: Performance shares awarded under long-term incentive plan based on performance during three-year period ended September 30, 2019. Read SEC document |
| November 30, 2018 Filed Dec 4, 2018 16:24 UTC | SURMODICS INC SRDX · Entity 72915 | GiftCommon Stock | 330 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-060860 · doc4.xml · nonDerivative · entry 2 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,543 Read SEC document |
| November 30, 2018 Filed Dec 4, 2018 16:24 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 413 | $60.59 | $25,023.67 |
DisclosureSEC source: 0001209191-18-060860 · doc4.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,873 Read SEC document |
| November 28, 2018 Filed Nov 29, 2018 16:16 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 687 | $60.06 | $41,261.22 |
DisclosureSEC source: 0001209191-18-060222 · doc4.xml · nonDerivative · entry 4 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,286 Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:16 UTC | SURMODICS INC SRDX · Entity 72915 | GrantEmployee Stock Option (right to buy) · Derivative | 12,292 | $0.00 Strike: $56.63 | $0.00 |
DisclosureSEC source: 0001209191-18-060222 · doc4.xml · derivative · entry 5 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,292 Underlying: Common Stock · 12,292 shares Expires 2025-11-27 F3 · derivative.exercise_date: The award vests in four equal installments on each of the first four anniversaries of the November 27, 2018 grant date. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:16 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 3,973 | $56.63 | $224,990.99 |
DisclosureSEC source: 0001209191-18-060222 · doc4.xml · nonDerivative · entry 3 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,973 F2 · shares: Shares withheld to satisfy taxes incident to vesting of performance share award. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:16 UTC | SURMODICS INC SRDX · Entity 72915 | GrantCommon Stock | 8,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-060222 · doc4.xml · nonDerivative · entry 2 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,946 F1 · shares: Performance shares awarded under long-term incentive plan based on performance during three-year period ended September 30, 2018. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:16 UTC | SURMODICS INC SRDX · Entity 72915 | GrantCommon Stock | 2,648 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-060222 · doc4.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,235 Read SEC document |
| August 29, 2018 Filed Sep 4, 2018 16:22 UTC | SURMODICS INC SRDX · Entity 72915 | GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-049186 · doc4.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,587 Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 15:58 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 1,212 | $52.81 | $64,008.39 |
DisclosureSEC source: 0001209191-18-036648 · doc4.xml · nonDerivative · entry 2 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,887 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018. F3 · price: Reflects the weighted average price of 1,212 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on June 6, 2018 with sale prices ranging from $52.45 to $53.20 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 15:58 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 13,788 | $51.62 | $711,784.82 |
DisclosureSEC source: 0001209191-18-036648 · doc4.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,099 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018. F2 · price: Reflects the weighted average price of 13,788 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on June 6, 2018 with sale prices ranging from $51.25 to $52.15 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 10, 2018 Filed Apr 12, 2018 16:23 UTC | SURMODICS INC SRDX · Entity 72915 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,266 | $0.00 Strike: $20.37 | $0.00 |
DisclosureSEC source: 0001209191-18-024738 · doc4.xml · derivative · entry 5 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,266 shares Expires 2019-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| April 10, 2018 Filed Apr 12, 2018 16:23 UTC | SURMODICS INC SRDX · Entity 72915 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,367 | $0.00 Strike: $12.40 | $0.00 |
DisclosureSEC source: 0001209191-18-024738 · doc4.xml · derivative · entry 4 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,367 shares Expires 2018-11-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| April 10, 2018 Filed Apr 12, 2018 16:23 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 13,415 | $37.75 | $506,416.25 |
DisclosureSEC source: 0001209191-18-024738 · doc4.xml · nonDerivative · entry 3 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,887 Read SEC document |
| April 10, 2018 Filed Apr 12, 2018 16:23 UTC | SURMODICS INC SRDX · Entity 72915 | Exercise / conversionCommon Stock | 13,266 | $20.37 | $270,228.42 |
DisclosureSEC source: 0001209191-18-024738 · doc4.xml · nonDerivative · entry 2 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 10, 2018 Filed Apr 12, 2018 16:23 UTC | SURMODICS INC SRDX · Entity 72915 | Exercise / conversionCommon Stock | 5,367 | $12.40 | $66,550.80 |
DisclosureSEC source: 0001209191-18-024738 · doc4.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2017 Filed Nov 30, 2017 20:28 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 436 | $33.10 | $14,431.60 |
DisclosureSEC source: 0001209191-17-063122 · doc4.xml · nonDerivative · entry 4 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,669 Read SEC document |
| November 28, 2017 Filed Nov 30, 2017 20:28 UTC | SURMODICS INC SRDX · Entity 72915 | GrantEmployee Stock Option (right to buy) · Derivative | 21,285 | $0.00 Strike: $33.20 | $0.00 |
DisclosureSEC source: 0001209191-17-063122 · doc4.xml · derivative · entry 5 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,285 Underlying: Common Stock · 21,285 shares Expires 2024-11-28 F3 · derivative.exercise_date: The award vests in four equal installments on each of the first four anniversaries of the November 28, 2017 grant date. Read SEC document |
| November 28, 2017 Filed Nov 30, 2017 20:28 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 3,146 | $33.20 | $104,447.20 |
DisclosureSEC source: 0001209191-17-063122 · doc4.xml · nonDerivative · entry 3 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,105 F2 · shares: Shares withheld to satisfy taxes incident to vesting of performance share award. Read SEC document |
| November 28, 2017 Filed Nov 30, 2017 20:28 UTC | SURMODICS INC SRDX · Entity 72915 | GrantCommon Stock | 6,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-063122 · doc4.xml · nonDerivative · entry 2 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,251 F1 · shares: Shares issued in connection with the vesting of a performance share award under long-term incentive plan based on performance during three-year period ended September 30, 2017. Read SEC document |
| November 28, 2017 Filed Nov 30, 2017 20:28 UTC | SURMODICS INC SRDX · Entity 72915 | GrantCommon Stock | 4,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-063122 · doc4.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,726 Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 17:02 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 1,226 | $24.85 | $30,469.29 |
DisclosureSEC source: 0001209191-17-041109 · doc4.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,208 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2017. F2 · price: Reflects the weighted average price of 1,226 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on June 16, 2017 with sale prices ranging from $24.75 to $24.95 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 02, 2016 Filed Dec 2, 2016 18:47 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 1,264 | $23.90 | $30,215.79 |
DisclosureSEC source: 0001209191-16-153167 · doc4.xml · nonDerivative · entry 4 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,434 F3 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2016. F4 · price: Reflects the weighted average price of 1,264 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on December 2, 2016 with sale prices ranging from $23.75 to $24.075 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 18:47 UTC | SURMODICS INC SRDX · Entity 72915 | GrantEmployee Stock Option (right to buy) · Derivative | 17,121 | $0.00 Strike: $23.95 | $0.00 |
DisclosureSEC source: 0001209191-16-153167 · doc4.xml · derivative · entry 5 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,121 Underlying: Common Stock · 17,121 shares Expires 2023-11-30 F5 · derivative.exercise_date: The award vests in four equal installments on each of the first four anniversaries of the November 30, 2016 grant date. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 18:47 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 2,353 | $23.95 | $56,354.35 |
DisclosureSEC source: 0001209191-16-153167 · doc4.xml · nonDerivative · entry 3 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,698 F2 · shares: Shares withheld to satisfy taxes incident to vesting of performance share award. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 18:47 UTC | SURMODICS INC SRDX · Entity 72915 | GrantCommon Stock | 4,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-153167 · doc4.xml · nonDerivative · entry 2 Phillips Bryan K · CIK 0001412895 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,051 F1 · shares: Performance shares awarded under long-term incentive plan based on performance during three-year period ended September 30, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.